Article
Updates in the molecular pathology of non-small cell lung cancer.
Seminars in diagnostic pathology - 1 Sept 2021
Paver Elizabeth, O'Toole Sandra, Cheng Xin Min, Mahar Annabelle, Cooper Wendy A
Abstract excerpt
An understanding of the molecular pathology of non-small cell lung cancer (NSCLC) is important for pathologists as molecular characterization is now required for treatment decisions in advanced stage disease. While assessment for EGFR mutations, ALK and ROS1 fusions, and in some countries BRAF mutations, is now standard practice, other oncogenic mutations are also emerging that may impact routine clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.